GT Biopharma Appoints New Member to its Board of Directors
SAN FRANCISCO, CALIFORNIA, June 13, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc.…
Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics
Vancouver, Canada, June 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Engages Leading…
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
June 10, 2025 13:33 ET | Source: MiNK Therapeutics NEW YORK, June…
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 09, 2025 16:05 ET | Source: Vera Therapeutics BRISBANE, Calif., June…
Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
June 06, 2025 16:01 ET | Source: Keros Therapeutics, Inc. LEXINGTON, Mass.,…
Xilio Therapeutics Announces Closing of $50.0 Million Public Offering
June 05, 2025 18:38 ET | Source: Xilio Therapeutics, Inc. Total gross…
Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical…
Addex Convenes Annual General Meeting 2025
June 03, 2025 01:00 ET | Source: Addex Therapeutics Geneva, Switzerland, June…
Avistone Announces Encouraging Results for Vebreltinib plus Andamertinib (PLB1004) in EGFR-mutated NSCLC with MET Amplification or Overexpression at ASCO Annual Meeting 2025
BEIJING--(BUSINESS WIRE)--Beijing Avistone Biotechnology Co., Ltd (“Avistone”), an innovative biotechnology company focused…
